fellowship

Fellowship

Thank you for your interest in becoming a fellow of the British Society for Nanomedicine. To begin the fellowship application process please select which type of membership you require:

  1. Fellow is the highest and most prestigious honour that will be conferred upon members in acknowledgment of their outstanding achievements and significant impact in the field of nanomedicine.
  2. Associate Fellow is open to early-career members who have already showcased promising contributions to the field.

For more information on any of these roles and how to apply, please see the Fellowship Guidance Document linked below.

Applications will be reviewed throughout the year and appointment for Fellows and Associate Fellows will be formally announced at the BSNM Annual Meeting.

If you have any questions please contact us at britishsocietyfornanomedicine@gmail.com 

Download a copy of the Fellowship Guidance Document Here

Meet our Fellows

Dr Aristides Tagalakis, FBSNM
Dr Aristides Tagalakis, FBSNM

Dr Tagalakis is a Reader in Gene Delivery and Nanomedicine at Edge Hill University. The main objective of his current research has been to develop and evaluate different non-viral and nanoparticle technologies in gene therapy for cancer, cystic fibrosis, glaucoma, AD, CVD and other genetic disorders. Previously he worked as a Senior Research Fellow at UCL. He holds a PhD from The University of London. He has authored ~100 peer-reviewed publications (original research articles and conference proceedings) in high-impact international journals. He has been a member of the ‘Physical Delivery, Therapeutics and Vector Development’ and the ‘Nanoagents & Synthetic Formulations’ Scientific Committees of the American Society of Gene and Cell Therapy for 9 years. He is a reviewer of national and international project/programme grants and a regular reviewer of numerous leading scientific journals. He serves on editorial boards of scientific journals and is a consultant for pharmaceutical and biotech companies.

Key Research Activities and Highlights

  • UCL Institute of Child Health Research Excellence Award (2014)
  • Main Research Interest: Advanced Therapies using Nanomedicine
  • Fellow of: the Institute of Biomedical Sciences, the Royal Society of Biology, the British Society for Nanomedicine and the Higher Education Academy and a Full Member of the Biochemical Society.
Dr Mayank Singh, FBSNM
Dr Mayank Singh, FBSNM

Dr. Mayank Singh currently serves as Principal Scientist & Director of “The National Dendrimer & Nanotechnology Center” based in Mount Pleasant, Michigan, USA. Additionally, he holds a joint appointment as a Graduate Faculty and Adjunct Professor at “Central Michigan University College of Medicine” and Consultant for the “World Health Organization” in Geneva, Switzerland. He also contributes as an expert faculty member in Chemical Biology and Biomimetic Chemistry at Faculty Opinions in the United Kingdom. He has deep expertise in dendrimer technology and nanomedicine, with innovations that have resulted in multiple patents and commercially viable products.

Dr. Singh has received several prestigious recognitions, including designations as a Registered Scientist, Chartered Scientist, and Pharmaceutical Scientist. He is a Fellow of the Indian Chemical Society and the British Society for Nanomedicine. He has also been recognized as a biographical listee in a prominent U.S. registry honoring leaders in science and innovation.

Key Research Activities and Highlights:

  • Pioneered next-generation hybrid-dendrimer technology for advanced biomedical and pharmaceutical applications.
  • Translated dendrimer-based technologies from lab-scale innovations to clinical and industrial applications.
  • Established senolytics and anti-aging therapeutics, offering promising breakthroughs in regenerative medicine and skincare.
  • Engineered nano-excipient technologies for pharmaceuticals, enabling improved solubility, stability, and bioavailability.
  • Established green nanotechnology strategies for phytopharmaceutical innovation and sustainable pharmaceutical delivery.

Benefits of Fellowship

If your application is successful, the applicant will be informed by e-mail and receive a certificate.

Fellow benefits include:

  • The Fellow’s name will appear on the BSNM website.
  • This recognition could be used as part of the doctor’s title (FBSNM).
  • A nominal yearly fee of £50 will be requested for the maintenance of the fellowship.
  • The Fellows will benefit from reduced costs for attending the BSNM Annual Meetings.

Associate fellow benefits include:

  •  The Associate Fellow’s name will appear on the BSNM website.
  • This recognition could be used as part of the doctor’s title (AFBSN).
  • A nominal yearly fee of £25 will be requested for the maintenance of the Associate Fellowship.

The Society respects the privacy of all its members and will never pass on your details to any other party. Please read our Privacy Policy. Privacy Policy